COA recently hosted an educational webinar  surrounding the science, access, and affordability of biosimilars.

This instructional session was sponsored by Apobiologix, a COA Corporate member, and delivered by Edward Li, PharmD, MPH, BCOP, Associate Professor, University of New England College of Pharmacy.

COA is making a recording of the webinar available as continuing education for the COA membership at-large. During the one-hour long webinar, listeners will gain insights into:

• The definition and importance of a biosimilar
• The similarities and differences between biologic reference brands and generics
• Practice considerations in using biosimilars
• Billing and reimbursement issues
• The inclusion of biosimilars in pathways and payment models
• Formulary restrictions